New 趋势 in Opioids and Pain Management
August 7, 2024
Despite decreases in utilization and cost per claim, opioids remain the No. 1 drug class in Enlyte’s 2024 Drug 趋势 Report. 然而, due to concerns with safety and overutilization, increased focus on usage guidelines as well as alternatives to pain management are gaining momentum — including those whose active ingredients drive from things you might not imagine, like pufferfish, cacti and chili peppers. Enlyte’s Nikki Wilson explores this and more in our Part 3 drug trends analysis.
Ask The Pharmacist: GLP-1 Drugs in Workers’ Compensation
August 6, 2024
Glucagon-like peptide 1 (GLP-1) receptor agonists medications, originally designed for diabetes management, have skyrocketed in popularity over the past year as effective drugs for weight loss and obesity.
The 考文垂 VIP Program
2024年7月8日
In this article, 吉尔·哈里斯, 高级副总裁, Network Operations outlines how the 考文垂 VIP Program benefits all parties. She provides an overview and the components of the program's offerings, illustrating how investing in provider relationships serves as a foundation for a robust network strategy.
Looking Beyond the Numbers of Enlyte’s Medical Price Index
June 25, 2024
In this quarter’s Enlyte Executive Insight, Michele Hibbert, senior vice president of regulatory compliance management, discusses the latest results from Enlyte’s medical price index and how it impacts the industry.
Enlyte Pharmacists Discuss a Changing Workers’ Comp Pharmacy Landscape
June 24, 2024
Workers' compensation pharmacy is constantly evolving, from tackling the opioid crisis, to the rise of compounding pharmacies, to the pandemic. Amidst these changes, pharmacy benefit managers must constantly evolve to address an array of industry changes. In our final Enlytening Conversation our pharmacists discuss how changes within the industry as a whole including physician shortages, digital therapeutics, biopsychosocial approaches, new drug treatments, and much more are driving the need for constant planning and innovation to stay a step ahead in this ever-changing landscape.
Enlyte Pharmacy Experts Speak on Turning Challenges Into Opportunities
June 24, 2024
Clients face numerous challenges in managing their workers' compensation pharmacy programs including capturing all pharmacy utilization and costs as well as addressing abuse by price opportunists. In this Enlytening Conversation we’ll dig deeper into these issues and others to find proactive opportunities to address pharmacy challenges through identification, 监管, and continually reevaluating outcomes and analytics to better understand how the right pharmacy partner can positively impact overall spend and claims outcomes.
Enlyte Experts Discuss the Benefit of a Holistic Approach to Pharmacy
June 24, 2024
Seizing opportunity within the complexities of workers’ comp prescription utilization requires a holistic approach that manages all transactions to gain the full picture of medications being utilized. This Enlytening Conversation covers key factors for payers to consider that impact pharmacy utilization and cost, including legislative and regulatory challenges, physician dispensing, utilization controls, complex billing issues and cost management solutions that consider therapy as a whole.